Multiply high-level-aminoglycoside-resistant enterococci isolated from patients in a university hospital
about
The life and times of the EnterococcusBacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalisEpidemiologic evaluation of antimicrobial resistance in community-acquired enterococciEfficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditisIn vitro activities of an investigational quinolone, glycylcycline, glycopeptide, streptogramin, and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faecium.Occurrence of high-level aminoglycoside resistance in environmental isolates of enterococci.Molecular characterization of highly gentamicin-resistant Enterococcus faecalis isolates lacking high-level streptomycin resistance.Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit.Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study GroupEnterococci highly resistant to penicillin and ampicillin: an emerging clinical problem?Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis.Screening and treatment of infections caused by resistant enterococci.Evaluation of a commercial microtiter system (MicroScan) using both frozen and freeze-dried panels for detection of high-level aminoglycoside resistance in Enterococcus spp.Detection of enterococcal high-level aminoglycoside resistance with MicroScan freeze-dried panels containing newly modified medium and Vitek Gram-Positive Susceptibility cards.
P2860
Q24616875-9106C039-321C-44A4-B80D-D741F2A5A2CEQ24645094-66288CF8-4833-4D7F-82F6-89BDF189C7C0Q33660491-F301364C-6389-4C9B-A93F-96392C9FE44FQ35121434-58BEA37C-BC01-44B0-9CA2-8312C5185522Q35139128-94026FAB-A985-43E5-90FE-7F6ED2E5F3D1Q35182776-D84AC0BB-AA30-45FC-BD5C-2309595C0351Q35807947-F54C013D-FD79-415B-AB36-962683057337Q35821697-21076D38-6C98-42F3-B3B9-9DC264CFE741Q37126795-A305D122-F1CA-48D9-B12D-8FFF54705231Q37180294-0C8B6752-BDB4-40BD-B1BB-3C61D4064E14Q37242595-958A89A3-1D77-4CDB-99F4-4A8ABA1CE946Q37711795-2E8C71EA-CED2-4FCB-B910-2F9DF0C07423Q40201290-2ACFC2CD-DACE-45F1-83CB-CCBCC1D90424Q40212219-DA54EE3D-A925-451A-BD8D-54625CBFD638
P2860
Multiply high-level-aminoglycoside-resistant enterococci isolated from patients in a university hospital
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1988
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multiply high-level-aminoglyco ...... ients in a university hospital
@en
Multiply high-level-aminoglyco ...... ents in a university hospital.
@nl
type
label
Multiply high-level-aminoglyco ...... ients in a university hospital
@en
Multiply high-level-aminoglyco ...... ents in a university hospital.
@nl
prefLabel
Multiply high-level-aminoglyco ...... ients in a university hospital
@en
Multiply high-level-aminoglyco ...... ents in a university hospital.
@nl
P2093
P2860
P1476
Multiply high-level-aminoglyco ...... ients in a university hospital
@en
P2093
Fischer SH
MacGregor RR
Moellering RC Jr
Nachamkin I
Wennersten CB
P2860
P304
P407
P577
1988-07-01T00:00:00Z